NL8100745A - Bloeddrukverlagende aminen. - Google Patents

Bloeddrukverlagende aminen. Download PDF

Info

Publication number
NL8100745A
NL8100745A NL8100745A NL8100745A NL8100745A NL 8100745 A NL8100745 A NL 8100745A NL 8100745 A NL8100745 A NL 8100745A NL 8100745 A NL8100745 A NL 8100745A NL 8100745 A NL8100745 A NL 8100745A
Authority
NL
Netherlands
Prior art keywords
alkyl
compound according
group
carbon atoms
formula
Prior art date
Application number
NL8100745A
Other languages
English (en)
Dutch (nl)
Original Assignee
Usv Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usv Pharma Corp filed Critical Usv Pharma Corp
Publication of NL8100745A publication Critical patent/NL8100745A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
NL8100745A 1980-04-11 1981-02-16 Bloeddrukverlagende aminen. NL8100745A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/139,367 US4258042A (en) 1980-04-11 1980-04-11 Antihypertensive pyridines and compositions
US13936780 1980-04-11

Publications (1)

Publication Number Publication Date
NL8100745A true NL8100745A (nl) 1981-11-02

Family

ID=22486280

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8100745A NL8100745A (nl) 1980-04-11 1981-02-16 Bloeddrukverlagende aminen.

Country Status (23)

Country Link
US (1) US4258042A (fr)
JP (1) JPS56158762A (fr)
AR (2) AR227306A1 (fr)
AU (1) AU6941181A (fr)
BE (1) BE888327A (fr)
CA (1) CA1175825A (fr)
CH (1) CH647519A5 (fr)
DE (1) DE3109794A1 (fr)
DK (1) DK162581A (fr)
ES (1) ES499667A0 (fr)
FI (1) FI810981L (fr)
FR (1) FR2480284A1 (fr)
GB (1) GB2073739B (fr)
IL (1) IL62362A (fr)
IT (1) IT1137539B (fr)
LU (1) LU83293A1 (fr)
NL (1) NL8100745A (fr)
NO (1) NO811240L (fr)
NZ (1) NZ196787A (fr)
PH (1) PH15278A (fr)
SE (1) SE8101211L (fr)
ZA (1) ZA81802B (fr)
ZW (1) ZW8281A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
US4491582A (en) * 1983-03-03 1985-01-01 Usv Pharmaceutical Corporation N-(substituted piperazino)-1,4-dihydropyridine-3,5-carboxylic acid
US4500528A (en) * 1983-03-03 1985-02-19 Usv Pharmaceutical Corporation N-Substituted 1,4-dihydropyridines and pharmaceutical compositions
US4435395A (en) 1983-03-03 1984-03-06 Usv Pharmaceutical Corporation N-Substituted 1,4-dihydropyridazines and pharmaceutical compositions
US4503223A (en) * 1983-08-11 1985-03-05 Usv Pharmaceutical Corporation Process for the purification of N-morpholinoalkyl dihydropyridines
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
US4757071A (en) * 1984-12-14 1988-07-12 Nisshin Flour Milling Co., Ltd. 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
US4659717A (en) * 1985-08-21 1987-04-21 Eli Lilly And Company Dihydropyridines useful in the treatment of angina and stroke
DE3544211A1 (de) * 1985-12-13 1987-06-19 Bayer Ag Neue, fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4780538A (en) * 1986-02-12 1988-10-25 Merck & Co., Inc. Process for 1,4-dihydropyridine compounds using a titanamine catalyst
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5170767A (en) * 1974-12-17 1976-06-18 Yamanouchi Pharma Co Ltd Shinki nn chikan 1*44 jihidoropirijinjudotaino goseiho

Also Published As

Publication number Publication date
NZ196787A (en) 1984-04-27
FR2480284A1 (fr) 1981-10-16
JPS56158762A (en) 1981-12-07
IL62362A0 (en) 1981-05-20
US4258042A (en) 1981-03-24
CH647519A5 (de) 1985-01-31
ZA81802B (en) 1982-02-24
GB2073739A (en) 1981-10-21
IT8121078A0 (it) 1981-04-10
NO811240L (no) 1981-10-12
IL62362A (en) 1984-12-31
CA1175825A (fr) 1984-10-09
IT1137539B (it) 1986-09-10
BE888327A (fr) 1981-10-08
PH15278A (en) 1982-11-02
AR229435A1 (es) 1983-08-15
FI810981L (fi) 1981-10-12
ZW8281A1 (en) 1981-07-01
FR2480284B1 (fr) 1984-01-06
ES8202001A1 (es) 1982-02-01
ES499667A0 (es) 1982-02-01
DK162581A (da) 1981-10-12
DE3109794A1 (de) 1982-01-28
AU6941181A (en) 1981-10-15
LU83293A1 (fr) 1981-12-02
GB2073739B (en) 1984-07-11
SE8101211L (sv) 1981-10-12
AR227306A1 (es) 1982-10-15

Similar Documents

Publication Publication Date Title
NL8100745A (nl) Bloeddrukverlagende aminen.
JP4634560B2 (ja) 光学活性なインドリン誘導体の製造方法およびその製造中間体
PL131190B1 (en) Process for preparing novel derivatives of dihydropyridine
PL140278B1 (en) Method of obtaining novel derivatives of 1,4-dihydropyridine
CA1320204C (fr) Amides et esters d'acide dihydropyridinyldicarboxylique, utilisables en pharmacie
JPH0524917B2 (fr)
PT91330A (pt) Processo para a preparacao de novos derivados de guanina
EP0260491B1 (fr) 9-Déazaguanines
CS241549B2 (en) Method of 1,4-dihydropyridines production
RU98115533A (ru) Новые производные бензоилгуанидина, способ их получения и их применение при получении лекарственных средств
FI62085B (fi) Analogifoerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-oxo-1,6,7,8-tetrahydro-4h-pyrido-(1,2-a)pyrimidinderivat
US4988702A (en) Novel 9-deazaguanines
FR2650591A1 (fr) Nouveaux derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPS62281860A (ja) アルキレンアミノアルキレン ヘテロ原子基を有するジヒドロ−3,5−ジカルボキシレ−ト
JP3712529B2 (ja) 3,3−ジピリジルアクリル酸アミド誘導体又はその薬学的に許容される塩
US4520131A (en) Antihypertensive N-substituted 1,4-dihydropyridines
US3378564A (en) Certain pyridyl tetrazole derivatives
US4500528A (en) N-Substituted 1,4-dihydropyridines and pharmaceutical compositions
HUT52055A (en) Process for producing basic 4-aryl-dihydropyridin-amides and pharmaceutical compositions containing them
US4500532A (en) 1-(Substituted aminoalkyl)-1,4-dihydropyridines
US5061707A (en) 9-deazaguanines to treat psoriasis
NL8502899A (nl) 6-fenethylaminoalkyl-furo-(3,4-c)-pyridinederivaten, werkwijzen voor het bereiden van deze derivaten en therapeutische preparaten die zij bevatten.
Birnberg et al. The synthesis of 5‐arylpyrrolo [3, 2‐b] pyridines and 7‐arylpyrrolo [3, 2‐b] pyridines: Addition of 3‐aminopyrroles to aryl enaminones
EP0025965A2 (fr) Composés d'organogermanium, procédé pour leur préparation et compositions pharmaceutiques les contenant
US4435395A (en) N-Substituted 1,4-dihydropyridazines and pharmaceutical compositions

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed